China Science and Technology Innovation operates as an investment firm.
China Science and Technology Innovation operates as an investment firm.
| 
                        Date
                        Company Name
                     | Round | Money Raised | Industry | Lead Investor | 
|---|---|---|---|---|
| 
                      Jan 12, 2023
                      
                            LePure Biotech | Series C | — | Biopharma | — | 
| 
                      Apr 13, 2022
                      
                            Guangdong Gaojing Solar Energy Technology | Series A | ¥1.60B | Energy | — | 
| 
                      Mar 18, 2022
                      
                            Xinling Pharmaceutical | Seed | ¥100M | — | |
| 
                      Dec 20, 2021
                      
                            Vastai Technologies | Series B | ¥1.60B | Artificial Intelligence | — | 
| 
                      Mar 17, 2021
                      
                           | Series B | ¥200M | Health Care | — |